Europe & Asia
phone: +49 (0)941 942 76-100
fax:        +49 (0)941 942 76-780
US & Canada
phone:+1-877-720-GENE (4363)
fax:       +1-416-233-0854

Latest press releases

23. February 2010
GENEART Publishes Preliminary Results for 2009
> more  > deutsche Version 
26. November 2009
GENEART Supports iGEM Winning Teams for Third Consecutive Year
> more  > deutsche Version 
19. November 2009
World’s Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol
> more  > deutsche Version 
12. November 2009
GENEART Publishes Results for Third Quarter 2009
> more  > deutsche Version 
14. October 2009
Deutschland – Land der Ideen: Biotech-Unternehmen GENEART ist „Ausgewählter Ort im Land der Ideen“ und damit Botschafter für Innovation und neues, frisches Denken
> more  > deutsche Version 
16. September 2009
GENEART is new Research Partner of the PolyModE Joint Project Supported by the EU Commission
> more  > deutsche Version 
13. August 2009
GENEART Publishes Financial Results for First Half 2009
> more  > deutsche Version 
16. July 2009
GENEART Ploughs Back Accumulated Profit for Further Company Growth
> more  > deutsche Version 
07. July 2009
Actelion Chooses GENEART as Exclusive Supplier for DNA Engineering & Processing Services
> more  > deutsche Version 
02. July 2009
GENEART Again Honored with “BAVARIA’S BEST 50” Award
> more  > deutsche Version 
24. June 2009
GENEART Supports iGEM Contest for the Third Year in a Row
> more  > deutsche Version 
19. June 2009
GENEART Supports the UK HIV Vaccine Consortium (UK HVC) in Developing a DNA Vaccine Candidate against HIV
> more  > deutsche Version 
04. June 2009
GENEART Receives Major Contract from Max Planck Institute for Molecular Genetics within the BMBF Joined Project “IG Mutanom”
> more  > deutsche Version 
02. June 2009
GENEART Appoints Daniel Seibert as New Chief Financial Officer
> more  > deutsche Version 
28. May 2009
GENEART AG Publishes Financial Result for the 1st Quarter 2009
> more  > deutsche Version 
04. May 2009
GENEART Synthesizes Genes for Swine Flu Vaccine in Record Speed
> more  > deutsche Version 
30. April 2009
GENEART AG Publishes Consolidated Financial Statements 2008
> more  > deutsche Version 
12. March 2009
GENEART Publishes Preliminary Results 2008 (Consolidated Financial Statement IFRS)
> more  > deutsche Version 
05. February 2009
GENEART receives European Patent for Screening Process for Antiviral Therapeutics
> more  > deutsche Version 
20. January 2009
GENEART Receives European Patent for Selective Evolution of Proteins
> more  > deutsche Version 
16. December 2008
GENEART and MorphoSys Successfully Cooperate in HuCAL PLATINUM® Project
> more  > deutsche Version 
26. November 2008
GENEART receives major contract from the Wellcome Trust Sanger Institute
> more  > deutsche Version 
13. November 2008
GENEART AG Publishes Final Numbers for the First Nine Months and the Third Quarter 2008
> more  > deutsche Version 
12. November 2008
GENEART Supports iGEM Winning Teams Again
> more  > deutsche Version 
10. November 2008
GENEART Successfully Concludes Project to Complete the National Institutes of Health’s “Mammalian Gene Collection“
> more  > deutsche Version 
06. November 2008
GENEART AG Publishes Preliminary Figures for Q3 2008
> more  > deutsche Version 
23. October 2008
GENEART again among Germany‘s Top “Technology Fast 50” Companies
> more  > deutsche Version 
09. October 2008
GENEART Reaches Contest Final ”Entrepreneur of the Year 2008“
> more  > deutsche Version 
07. October 2008
GENEART wins „European Biotechnica Award“
> more  > deutsche Version 
01. October 2008
GENEART Presents its Work at the Most Important International Conference on Synthetic Biology in Hong Kong
> more  > deutsche Version 
17. September 2008
GENEART Supports Advancements in Synthetic Biology as Partner of the iGEM Competition
> more  > deutsche Version 
08. September 2008
GENEART Founds a Subsidiary on the West Coast of the US
> more  > deutsche Version 
04. September 2008
GENEART Extends Strategic Partnership with QIAGEN to Commercialize Synthetic Human Genes
> more  > deutsche Version 
25. August 2008
GENEART has been elected Finalist of the “European Biotechnica Award 2008”
> more  > deutsche Version 
13. August 2008
GENEART Combines Net Sales Growth with Strong Earnings in the 1st Half-year of 2008
> more  > deutsche Version 
24. July 2008
GENEART Plows Back Profits to further Boost the Strong Company Growth
> more  > deutsche Version 
10. July 2008
GENEART Receives a Grant for the Targeted Design of Vaccine Candidates
> more  > deutsche Version 
01. July 2008
The US National Cancer Institute Expands Contract with GENEART by USD 0.8M
> more  > deutsche Version 
24. June 2008
Boehringer Ingelheim and GENEART Collaborate on Offering Design and Production Services for DNA Therapeutics and Vaccines
> more  > deutsche Version 
29. May 2008
First Quarter of 2008 Results in Stable Growth and New Market Opportunities
> more  > deutsche Version 
14. May 2008
QIAGEN and GENEART Partner to Commercialize Synthetic Mammalian Genes
> more  > deutsche Version 
30. April 2008
GENEART Presents Financial Statements for 2007 and Preliminary Results for the First Quarter 2008
> more  > deutsche Version 
24. April 2008
The US National Cancer Institute Extends its Contract with GENEART – Order Volume USD 1.9M
> more  > deutsche Version 
09. April 2008
GENEART is Awarded a European Patent for Successfully Tested HIV Vaccines
> more  > deutsche Version 
07. April 2008
German Patent Protects Novel Screening Method for Antiviral Therapeutics Based on Synthetic Genes
> more  > deutsche Version 
17. March 2008
GENEART is Awarded a Grant to Advance Its GeneOptimizer® Technology as Part of a Collaborative EU Project
> more  > deutsche Version 
20. February 2008
GENEART is Awarded two US Patents for Successfully Tested HIV Vaccines
> more  > deutsche Version 
14. February 2008
GENEART is Nominated for the Oskar Patzelt Foundation Award for Midsized Enterprises
> more  > deutsche Version 
06. February 2008
GENEART Expects its Positive Business Development to Continue in 2008 after significant Sales and Earnings Growth in 2007
> more  > deutsche Version 
28. January 2008
GENEART supports the Craig Venter Institute to create the first synthetic bacterial genome
> more  > deutsche Version 
Print PDF